--- title: "Medpace Holdings (MEDP) news: class action" url: "https://aibio.space/companies/medpace/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "MEDP class action news: Medpace discloses plaintiff dropped Ohio securities class action over book-to-bill ratio. Medpace Holdings, Inc." --- MEDP Medpace Holdings, Inc. NASDAQ · United States # Medpace Holdings (MEDP) news MEDP class action news Legal · 2026-10-22 ## [Medpace discloses plaintiff dropped Ohio securities class action over book-to-bill ratio](https://aibio.space/news/medpace-discloses-plaintiff-dropped-ohio-securities-class-action-book/) Defendants: Medpace Holdings, August J. Troendle, Jesse J. Geiger and Kevin M. Brady. Plaintiff filed a voluntary dismissal without prejudice on October 12, and a derivative suit was also dropped. ## Latest Medpace Holdings news We have not published a story on Medpace Holdings yet. When there is news, it will appear here. ## Medpace Holdings at a glance - **Ticker**: MEDP - **Listing**: NASDAQ - **Country**: United States - **Cash, Sep 30, 2026**: $705.3 million ### Related companies - [Vicarious Surgical](https://aibio.space/companies/vicarious-surgical/) OTC: RBOT - [Cannaisseur Group](https://aibio.space/companies/cannaisseur/) OTC: TCRG - [Asep Medical Holdings](https://aibio.space/companies/asep-medical/) OTC: SEPSF - [PULSE BIOSCIENCES, INC.](https://aibio.space/companies/pulse-biosciences/) NASDAQ: PLSE - [RadNet](https://aibio.space/companies/radnet/) NASDAQ: RDNT - [WATERS CORP /DE/](https://aibio.space/companies/waters-de/) NYSE: WAT - [PHIBRO ANIMAL HEALTH CORP](https://aibio.space/companies/phibro-animal-health/) NASDAQ: PAHC - [CONMED](https://aibio.space/companies/conmed/) NYSE: CNMD ### Also on NASDAQ - [MBX Biosciences](https://aibio.space/companies/mbx-biosciences/) MBX - [Anixa Biosciences](https://aibio.space/companies/anixa-biosciences/) ANIX - [Cullinan Therapeutics](https://aibio.space/companies/cullinan-therapeutics/) CGEM - [Lipocine](https://aibio.space/companies/lipocine/) LPCN - [UFP TECHNOLOGIES INC](https://aibio.space/companies/ufp-technologies/) UFPT - [Quantum Biopharma](https://aibio.space/companies/quantum-biopharma/) QNTM ## Medpace Holdings annual financials | Line | FY2025 | FY2024 | |---|---|---| | Revenue | [$2.53 billion](https://www.sec.gov/Archives/edgar/data/1668397/000166839726000006/) | [$2.11 billion](https://www.sec.gov/Archives/edgar/data/1668397/000166839726000006/) | | Net income (loss) | [$451.1 million](https://www.sec.gov/Archives/edgar/data/1668397/000166839726000006/) | [$404.4 million](https://www.sec.gov/Archives/edgar/data/1668397/000166839726000006/) | | Cash from operations | [$713.2 million](https://www.sec.gov/Archives/edgar/data/1668397/000166839726000006/) | [$608.8 million](https://www.sec.gov/Archives/edgar/data/1668397/000166839726000006/) | | Cash and equivalents | [$497.0 million](https://www.sec.gov/Archives/edgar/data/1668397/000166839726000036/) | [$669.4 million](https://www.sec.gov/Archives/edgar/data/1668397/000166839726000006/) | Latest balance sheet, Sep 30, 2026 (10-Q): cash and equivalents $705.3 million. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about Medpace Holdings Is there a class action against Medpace Holdings? Our latest story on this, dated Oct 22, 2026: "Medpace discloses plaintiff dropped Ohio securities class action over book-to-bill ratio". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/medpace-discloses-plaintiff-dropped-ohio-securities-class-action-book/). What is the ticker symbol of Medpace Holdings? Medpace Holdings, Inc. trades under the ticker MEDP on NASDAQ. Where is Medpace Holdings listed? Medpace Holdings, Inc. is listed on NASDAQ. Which country or territory is Medpace Holdings listed under? Our directory records Medpace Holdings, Inc. under United States. Does aibio.space cover Medpace Holdings? aibio.space lists Medpace Holdings, Inc. among 2,820 public biotech companies and publishes its news here as stories appear. What was Medpace Holdings's revenue last year? $2.53 billion for the fiscal year ended Dec 31, 2025, as reported to the SEC. Is Medpace Holdings profitable? Medpace Holdings, Inc. reported net income of $451.1 million for the fiscal year ended Dec 31, 2025, and generated $713.2 million of cash from operations, per its annual report to the SEC. How much cash does Medpace Holdings have? $705.3 million in cash at Sep 30, 2026, per its 10-Q. What is the latest Medpace Holdings (MEDP) stock news? Our latest story on Medpace Holdings, dated Oct 22, 2026: "Medpace discloses plaintiff dropped Ohio securities class action over book-to-bill ratio". Defendants: Medpace Holdings, August J. Troendle, Jesse J. Geiger and Kevin M. Brady. Plaintiff filed a voluntary dismissal without prejudice on October 12, and a derivative suit was also dropped. [Source](https://aibio.space/news/medpace-discloses-plaintiff-dropped-ohio-securities-class-action-book/). How can I follow Medpace Holdings (MEDP) news? Press Follow on this page to add Medpace Holdings to your Following list, or subscribe to the aibio.space newsletter. We have published 1 story naming Medpace Holdings so far, in Legal. ## Investor discussion: Medpace Holdings Members talk about Medpace Holdings (MEDP). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:MEDP on TradingView](https://www.tradingview.com/symbols/NASDAQ-MEDP/). ## Listing details Medpace Holdings, Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker MEDP, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Medpace Holdings, Inc. - **Ticker**: MEDP - **Listing**: NASDAQ - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/medpace/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Medpace Holdings (MEDP) news: class action", 2026-10-31, https://aibio.space/companies/medpace/